This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Looking for Computer and Technology Stocks? The Zacks Rank Can Help You Find Winners
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Rank.
3 Reasons to Add LHC Group (LHCG) Stock to Your Portfolio
by Zacks Equity Research
Investors continue to be optimistic about LHC Group (LHCG) owing to its slew of deals and a broad array of services.
OPKO Health (OPK) Inks Licensing Deal for AntagoNAT Technology
by Zacks Equity Research
OPKO Health's (OPK) latest licensing agreement is expected to advance the development and commercialization of potential disease-modifying therapeutics, especially for Dravet syndrome.
Inogen (INGN) Hits New 52-Week High: What's Driving It?
by Zacks Equity Research
Investors are optimistic about Inogen's (INGN) direct-to-customer business model and a strong product portfolio.
BD's (BDX) Digital Marketplace Set to Improve User Experience
by Zacks Equity Research
BD's (BDX) latest online marketplace is expected to offer a better user experience to its flow cytometry users.
Smith+Nephew's (SNN) New Device to Boost Patient Outcomes
by Zacks Equity Research
Smith+Nephew's (SNN) FAST-FLIX FLEX Meniscal Repair System to provide long-term benefits to patients.
Here's Why You Should Retain Merit Medical (MMSI) Stock Now
by Zacks Equity Research
Merit Medical (MMSI) continues to gain traction from robust Peripheral Intervention arm and solid international presence. Forex, although, remains a concern.
McKesson (MCK) Enters Deal to Divest Some European Businesses
by Zacks Equity Research
McKesson (MCK) to sell off some of its European ventures to streamline its business and prioritize investments in areas where it has better expertise.
The Zacks Analyst Blog Highlights: Zoom, Digital Turbine, ServiceNow and Veeva Systems
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Zoom, Digital Turbine, ServiceNow and Veeva Systems
4 Stocks to Buy on Increased Cloud Infrastructure Spending
by Ritujay Ghosh
The cloud-based service market has been growing in importance since the coronavirus outbreak, helping companies like Digital Turbine (APPS), Zoom Video Communications (ZM) and ServiceNow (NOW).
Here's Why You Should Retain AmerisourceBergen (ABC) Now
by Zacks Equity Research
AmerisourceBergen (ABC) continues to gain traction from robust pharmaceutical segment.
Intuitive Surgical (ISRG) Hits 52-Week High: What's Behind It?
by Zacks Equity Research
Investors are optimistic about Intuitive Surgical's (ISRG) strength in its da Vinci surgical system.
Surmodics (SRDX) Boosts Portfolio With Vetex Medical Buyout
by Zacks Equity Research
Surmodics' (SRDX) buyout of Vetex Medical adds second FDA 510 (k) cleared device to its thrombectomy platform.
Here's Why You Should Retain McKesson (MCK) Stock Right Now
by Zacks Equity Research
McKesson (MCK) continues to benefit from its robust Distribution Solutions segment.
West Pharmaceutical (WST) Hits 52-Week High: What's Driving It?
by Zacks Equity Research
Investors are optimistic about West Pharmaceutical's (WST) solid proprietary products segment.
Here's Why You Should Retain Allscripts (MDRX) Stock for Now
by Zacks Equity Research
Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances and solid prospects of the Sunrise EHR platform.
Here's Why You Should Retain PerkinElmer (PKI) Stock Now
by Zacks Equity Research
PerkinElmer (PKI) continues to gain traction on a solid product portfolio and improving margins. However, forex woes linger.
Bowen Center Expands Access to Care via NextGen's (NXGN) Platform
by Zacks Equity Research
NextGen's (NXGN) platform is likely to expand care to the underserved patient pool by improving the access to and delivery of whole-person care.
LHC Group (LHCG) Boosts Home Health, Hospice Arms With Buyouts
by Zacks Equity Research
LHC Group's (LHCG) three new buyouts and completion of previous acquisitions will enable the company to bolster its home health and hospice presence throughout seven states.
Here's Why You Should Retain Glaukos (GKOS) Stock Right Now
by Zacks Equity Research
Glaukos Corporation (GKOS) continues to benefit from robust product portfolio and solid performing iStent technology.
Here is Why Growth Investors Should Buy Veeva (VEEV) Now
by Zacks Equity Research
Veeva (VEEV) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Walgreens Boots (WBA) Q3 Earnings Top Estimates, 2021 View Up
by Zacks Equity Research
Walgreens Boots (WBA) revenues improve 12.1% year-over-year in the third quarter on robust growth in the International and United States segments.
3 Reasons to Add AMN Healthcare (AMN) to Your Portfolio
by Zacks Equity Research
Investors continue to be optimistic about AMN Healthcare (AMN) due to its broad array of services and strength in staffing service.
Reasons to Add West Pharmaceutical (WST) to Your Portfolio
by Zacks Equity Research
Investors continue to be optimistic about West Pharmaceutical (WST) due to its solid proprietary products segment.
Abbott (ABT) CE-Marked Panbio Test Now Widely Offered in Europe
by Zacks Equity Research
Abbott's (ABT) Panbio COVID-19 Antigen Self-Test is expected to facilitate mass screenings and aid in resumption of daily life activities with the gradual reopening of economies worldwide.